DE2327509A1 - O-(nitroaryl)oxime der 3-ketosteroide - Google Patents
O-(nitroaryl)oxime der 3-ketosteroideInfo
- Publication number
- DE2327509A1 DE2327509A1 DE2327509A DE2327509A DE2327509A1 DE 2327509 A1 DE2327509 A1 DE 2327509A1 DE 2327509 A DE2327509 A DE 2327509A DE 2327509 A DE2327509 A DE 2327509A DE 2327509 A1 DE2327509 A1 DE 2327509A1
- Authority
- DE
- Germany
- Prior art keywords
- imino
- nitrophenoxy
- group
- androstan
- acetoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000002923 oximes Chemical class 0.000 title description 5
- -1 2-hydroxy-5-nitrophenyl Chemical group 0.000 claims description 25
- 150000001875 compounds Chemical class 0.000 claims description 23
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 7
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 4
- 229930194542 Keto Natural products 0.000 claims description 4
- 239000003433 contraceptive agent Substances 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 125000000468 ketone group Chemical group 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 230000001195 anabolic effect Effects 0.000 claims description 2
- 150000001502 aryl halides Chemical class 0.000 claims description 2
- 239000003054 catalyst Substances 0.000 claims description 2
- 230000002254 contraceptive effect Effects 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- QZLYKIGBANMMBK-UGCZWRCOSA-N 5α-Androstane Chemical compound C([C@@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CCC[C@@]2(C)CC1 QZLYKIGBANMMBK-UGCZWRCOSA-N 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000001548 androgenic effect Effects 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- XEHVFKKSDRMODV-UHFFFAOYSA-N ethynyl Chemical compound C#[C] XEHVFKKSDRMODV-UHFFFAOYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 241000700159 Rattus Species 0.000 description 10
- 239000013078 crystal Substances 0.000 description 9
- 238000002844 melting Methods 0.000 description 9
- 230000008018 melting Effects 0.000 description 9
- 239000000460 chlorine Substances 0.000 description 8
- 238000002425 crystallisation Methods 0.000 description 8
- 230000008025 crystallization Effects 0.000 description 8
- 238000000921 elemental analysis Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 210000002307 prostate Anatomy 0.000 description 6
- GCKMFJBGXUYNAG-UHFFFAOYSA-N 17alpha-methyltestosterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C)(O)C1(C)CC2 GCKMFJBGXUYNAG-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- GCKMFJBGXUYNAG-HLXURNFRSA-N Methyltestosterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)CC2 GCKMFJBGXUYNAG-HLXURNFRSA-N 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 229960001566 methyltestosterone Drugs 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000027326 copulation Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 229940124558 contraceptive agent Drugs 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- QUKZBUCPOSYYFO-SSCHMFMQSA-N (8R,9S,10S,13S,14S,17S)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ol Chemical compound C1CCC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC21 QUKZBUCPOSYYFO-SSCHMFMQSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229940124325 anabolic agent Drugs 0.000 description 1
- 239000003263 anabolic agent Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- YLACRFYIUQZNIV-UHFFFAOYSA-N o-(2,4-dinitrophenyl)hydroxylamine Chemical compound NOC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O YLACRFYIUQZNIV-UHFFFAOYSA-N 0.000 description 1
- OOHKBWPOLBTKMR-UHFFFAOYSA-N o-(4-nitrophenyl)hydroxylamine Chemical compound NOC1=CC=C([N+]([O-])=O)C=C1 OOHKBWPOLBTKMR-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000003408 postcoitus contraceptive agent Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US259092A US3862193A (en) | 1970-12-02 | 1972-06-02 | O-(nitroaryl) oximes of 3-keto steroids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2327509A1 true DE2327509A1 (de) | 1973-12-13 |
Family
ID=22983493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2327509A Withdrawn DE2327509A1 (de) | 1972-06-02 | 1973-05-30 | O-(nitroaryl)oxime der 3-ketosteroide |
Country Status (9)
| Country | Link |
|---|---|
| BE (1) | BE800405R (enrdf_load_stackoverflow) |
| CA (1) | CA998041A (enrdf_load_stackoverflow) |
| CH (1) | CH593303A5 (enrdf_load_stackoverflow) |
| DE (1) | DE2327509A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2186263B2 (enrdf_load_stackoverflow) |
| GB (1) | GB1429951A (enrdf_load_stackoverflow) |
| IL (3) | IL42423A (enrdf_load_stackoverflow) |
| NL (1) | NL7307703A (enrdf_load_stackoverflow) |
| ZA (1) | ZA733706B (enrdf_load_stackoverflow) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3211756A (en) * | 1963-07-23 | 1965-10-12 | Searle & Co | 3-hydroxyimino-17alpha-(lower alkyl)-5alpha-androstan-17beta-ols and the optionally substituted 3-acyloxyimino and 3-alkoxyimino derivatives corresponding |
| US3686237A (en) * | 1969-12-04 | 1972-08-22 | Ortho Pharma Corp | O-(nitroaryl)oximes of 3-keto steroids |
-
1973
- 1973-05-23 CA CA171,985A patent/CA998041A/en not_active Expired
- 1973-05-30 DE DE2327509A patent/DE2327509A1/de not_active Withdrawn
- 1973-05-30 FR FR7319809A patent/FR2186263B2/fr not_active Expired
- 1973-05-30 ZA ZA00733706A patent/ZA733706B/xx unknown
- 1973-06-01 NL NL7307703A patent/NL7307703A/xx not_active Application Discontinuation
- 1973-06-01 BE BE131839A patent/BE800405R/xx active
- 1973-06-01 IL IL42423A patent/IL42423A/en unknown
- 1973-06-01 GB GB2634873A patent/GB1429951A/en not_active Expired
- 1973-06-01 CH CH796273A patent/CH593303A5/xx not_active IP Right Cessation
- 1973-06-01 IL IL50345A patent/IL50345A/en unknown
-
1976
- 1976-08-24 IL IL50345A patent/IL50345A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH593303A5 (enrdf_load_stackoverflow) | 1977-11-30 |
| IL50345A0 (en) | 1976-10-31 |
| GB1429951A (en) | 1976-03-31 |
| FR2186263A2 (enrdf_load_stackoverflow) | 1974-01-11 |
| ZA733706B (en) | 1975-01-29 |
| IL42423A0 (en) | 1973-08-29 |
| IL50345A (en) | 1977-02-28 |
| AU5642873A (en) | 1974-12-05 |
| IL42423A (en) | 1977-02-28 |
| BE800405R (fr) | 1973-12-03 |
| FR2186263B2 (enrdf_load_stackoverflow) | 1976-08-13 |
| CA998041A (en) | 1976-10-05 |
| NL7307703A (enrdf_load_stackoverflow) | 1973-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1620073A1 (de) | N-Substituiere,in 3-Stellung acylierte Chlor-3,4-dihydro-1,2-benzthiazin-3-on-1,1-dioxyde und ein Verfahren zu ihrer Herstellung | |
| DE2633210C2 (de) | Verwendung von D-17β-Acetoxy-13β-äthyl-17α-äthinyl-gon-4-en-3-on-oxim zur Hemmung der Fertilität und Ovulation | |
| DE1543273C3 (de) | 7 alpha-Methyl-Delta hoch 5(16) -steroide der Oestranreihe und Verfahren zu deren Herstellung | |
| CH637408A5 (de) | Verfahren zur herstellung von 6-fluor-17-alpha-pregnanderivaten. | |
| DE2748291B2 (de) | Substituierte 13-Benzodioxan-4one und Verfahren zu ihrer Herstellung sowie Verwendung dieser Verbindungen bei der Bekämpfung von Entzündungen | |
| DE2327509A1 (de) | O-(nitroaryl)oxime der 3-ketosteroide | |
| DE2711149C3 (de) | N-Substituierte[4-Chlor-6-(23-xylidino)-2· pyrimidinyl- thio] essigsäureamide sowie Verfahren zu deren Herstellung | |
| DE2708327A1 (de) | Entzuendungshemmendes mittel | |
| DE2614138C2 (de) | Benzo[b]thienylcarbonylpropyl- bzw. Butylamine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| DE1668611B1 (de) | 3-(ss-Diaethylaminoaethoxy)-16-oxo-delta?-OEstratrien,3-(ss-Diaethylaminoaethoxy)-17-oxo-delta?-lumi-oestratrien und deren Chlorhydrate und Verfahren zu deren Herstellung | |
| DE2059190A1 (de) | Aryloxime von Ketosteroiden und Verfahren zu ihrer Herstellung | |
| DE1593204C (de) | 19-nor-Delta hoch 4,6 -3,20-Diketosteroide, Verfahren zu ihrer Herstellung und Arzneimittel | |
| DE1593515C3 (de) | 6-Chlor-21 -fluor-1,2alpha-methylen-DeKa hoch 4,6 -pregnadiene, Verfahren zu deren Herstellung sowie diese enthaltende Mittel | |
| DE1620102C3 (de) | 3-Oxime der Androsten- und Gonenreihe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel | |
| DE2100319B2 (de) | Neue Östranverbindungen, ihre Herstellung und sie enthaltende Arzneimittel | |
| DE1595951A1 (de) | Verfahren zur Herstellung von Desoxyuridinverbindungen | |
| AT281840B (de) | Verfahren zur Herstellung von neuen 1,4-Benzodiazepinen bzw. von Salzen hievon | |
| DE1242608B (de) | Verfahren zur Herstellung von 1beta-Methyl-2, 3alpha-methylensteroiden | |
| CH579592A5 (en) | 3-ketosteroid oximes anabolic androgenic - antifertility | |
| DE1668689C3 (de) | N-substltuierte 4-Amlno-l alpha, 2 alpha-Methylen-deita hoch 4,6 -Pregnane | |
| DE1468681C3 (de) | 17beta-Tetrahydropyranyloxy verbindungen der Androstanreihe sowie Verfahren zu ihrer Herstellung und Heilmittel | |
| AT337373B (de) | Verfahren zur herstellung von neuen 21-fluor-19-norpregnadienverbindungen | |
| DE1922126C3 (de) | 6,17-Dichlor-A4'6 -pregnadiene, Verfahren zu deren Herstellung, diese enthaltende Arzneimittel sowie | |
| DE2134289C3 (de) | Pyrazolderivate | |
| AT270091B (de) | Verfahren zur Herstellung von neuen 1,2α,16,17α-Bismethylen-Δ<4,6>-pregnadienen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OD | Request for examination | ||
| 8130 | Withdrawal |